Hi,
I have my demat account with upstox and i want to apply for the rights issue of south indian bank. how can apply for the same since my netbanking doesn’t work. I tried many times but it never worked. So I went to linkintime where it says that I have to take the print out of the asba document and submit in the SCSB. Is there any other way too to apply through Upstox, so far I didn’t find anything related to rights issue in corporate actions in Upstox.
Posts in category Value Pickr
Special situation (demerger, rights issue, delisting) – checklist (06-03-2024)
Special situation (demerger, rights issue, delisting) – checklist (06-03-2024)
Hi,
I have my demat account with upstox and i want to apply for the rights issue of south indian bank. how can apply for the same since my netbanking doesn’t work. I tried many times but it never worked. So I went to linkintime where it says that I have to take the print out of the asba document and submit in the SCSB. Is there any other way too to apply through Upstox, so far I didn’t find anything related to rights issue in corporate actions in Upstox.
Neuland Laboratories Limited – Transformation towards niche APIs? (06-03-2024)
This is to inform you that the Company’s management will be participating in the following group analyst/ investor meetings:
Date Meeting Organized by Location
March 7, 2024 ICICI Securities Limited Hyderabad
Pursuant to Regulation 30 of SEBI Listing Regulations, we wish to inform you that Mr. Ashutosh Kumar Sinha has been appointed as Chief Quality Officer w.e.f. March 6, 2024.
Mr. Sinha holds M.Sc. in Pharmaceutical Chemistry from Institute of Chemists, Kolkata and is an MBA in Total Quality Management (TQM), from Sikkim Manipal University. He brings over 28 years of experience in the Quality function, working across organizations such as
Ranbaxy Labs Ltd, Glenmark Pharma Lab, Dr Reddys Lab and Symbiotec Pharmalab. Prior to joining us he was associated with Syngene International Ltd. as Associate
Vice President & Quality Head (Small molecule & Client dedicated centre).
His area of expertise, within the pharmaceutical Quality, include functions such as Corporate Quality Assurance, Plant Quality Assurance, Development Quality Assurance
(API & Formulation), among others.
Neuland Laboratories Limited – Transformation towards niche APIs? (06-03-2024)
This is to inform you that the Company’s management will be participating in the following group analyst/ investor meetings:
Date Meeting Organized by Location
March 7, 2024 ICICI Securities Limited Hyderabad
Pursuant to Regulation 30 of SEBI Listing Regulations, we wish to inform you that Mr. Ashutosh Kumar Sinha has been appointed as Chief Quality Officer w.e.f. March 6, 2024.
Mr. Sinha holds M.Sc. in Pharmaceutical Chemistry from Institute of Chemists, Kolkata and is an MBA in Total Quality Management (TQM), from Sikkim Manipal University. He brings over 28 years of experience in the Quality function, working across organizations such as
Ranbaxy Labs Ltd, Glenmark Pharma Lab, Dr Reddys Lab and Symbiotec Pharmalab. Prior to joining us he was associated with Syngene International Ltd. as Associate
Vice President & Quality Head (Small molecule & Client dedicated centre).
His area of expertise, within the pharmaceutical Quality, include functions such as Corporate Quality Assurance, Plant Quality Assurance, Development Quality Assurance
(API & Formulation), among others.
IIFL Finance (erstwhile IIFL Holdings) ~ Retail focused diversified NBFC (06-03-2024)
A take on the ban on IIFL Finance. No Offence to anyone, just saying there might an opportunity for other players IF the ban goes on for too long.
IIFL Finance (erstwhile IIFL Holdings) ~ Retail focused diversified NBFC (06-03-2024)
A take on the ban on IIFL Finance. No Offence to anyone, just saying there might an opportunity for other players IF the ban goes on for too long.
Journey and Portfolio of a goal-based NEEV investor (06-03-2024)
Yes it does, thanks for clarifying.
Journey and Portfolio of a goal-based NEEV investor (06-03-2024)
Yes it does, thanks for clarifying.